Finance

Beta
Ask
Lists
524711:BOM
Vista Pharmaceuticals Ltd
₹7.46
+0.67%
(+0.050) 1D
Jun 18, 3:29:59 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524711...
Mkt. cap
456.10M
Avg. vol.
10.92K
Volume
0.00
52-wk high
₹11.69
52-wk low
₹5.71
EPS
-₹1.96
Shares outstanding
29.15M
No. of employees
30
Mkt. cap
456.10M
Avg. vol.
10.92K
Volume
0.00
52-wk high
₹11.69
52-wk low
₹5.71
EPS
-₹1.96
Shares outstanding
29.15M
No. of employees
30
News stories
From sources across the web
About Vista Pharmaceuticals Ltd
CEO-
Employees30
Founded1991
Headquarters-
SectorPharmaceutical industry
Websitevistapharmaceuticals.com
Last report
Feb 13, 2026
Fiscal period
Q3 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
24.18M / -
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
32.30M
15.19M
14.62M
24.18M
Cost of goods sold
28.82M
14.98M
14.63M
22.60M
Cost of revenue
28.82M
14.98M
14.63M
22.60M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.53M
5.42M
5.68M
5.90M
Operating expense
13.09M
13.07M
36.36M
33.50M
Total operating expenses
41.91M
28.06M
50.99M
56.11M
Operating income
-9.61M
-12.87M
-36.37M
-31.93M
Other non operating income
-686.00K
-1.10K
1.92M
897.00K
EBT including unusual items
-10.62M
-14.80M
-36.22M
-32.80M
EBT excluding unusual items
-10.62M
-14.80M
-36.22M
-32.80M
Income tax expense
4.34M
-1.90M
-10.34M
-9.61M
Effective tax rate
-40.82%
12.82%
28.53%
29.30%
Other operating expenses
3.71M
5.89M
28.69M
25.74M
Net income
-14.96M
-12.90M
-25.88M
-23.19M
Net profit margin
-46.31%
-84.96%
-176.99%
-95.91%
Earnings per share
-
-
-
-
Interest and investment income
1.74M
-
-
-
Interest expense
-1.66M
-1.93M
-1.78M
-1.77M
Net interest expenses
82.00K
-1.93M
-1.78M
-1.77M
Depreciation and amortization charges
1.85M
1.76M
1.99M
1.87M
EBITDA
-7.77M
-11.02M
-34.49M
-30.08M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer